Progress towards the use of HIV protease inhibitors in cancer therapy.
Approaches to targeting the signaling pathways responsible for tumor survival are currently under intense investigation and there is ongoing rapid development of novel agents to target various signaling components that mediate tumor growth and survival. The development of agents as viable clinical i...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|